Compare CStone Pharmaceuticals Co. Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 10.28% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -359.62
2
Risky -
3
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
HKD 9,044 Million ()
NA (Loss Making)
NA
0.00%
-0.90
-66.06%
13.17
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2018)
Net Profit:
-176 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.44%
0%
18.44%
6 Months
-7.07%
0%
-7.07%
1 Year
-31.76%
0%
-31.76%
2 Years
295.89%
0%
295.89%
3 Years
199.48%
0%
199.48%
4 Years
54.55%
0%
54.55%
5 Years
-50.17%
0%
-50.17%
CStone Pharmaceuticals Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-24.37%
EBIT Growth (5y)
10.28%
EBIT to Interest (avg)
-203.35
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.89
Sales to Capital Employed (avg)
0.46
Tax Ratio
3.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.97
EV to EBIT
-15.38
EV to EBITDA
-17.21
EV to Capital Employed
104.39
EV to Sales
23.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-678.59%
ROE (Latest)
-66.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
292.40
441.50
-33.77%
Operating Profit (PBDIT) excl Other Income
-403.30
-49.40
-716.40%
Interest
14.40
16.40
-12.20%
Exceptional Items
-19.00
-4.70
-304.26%
Consolidate Net Profit
-473.90
-98.90
-379.17%
Operating Profit Margin (Excl OI)
-1,542.50%
-234.20%
-130.83%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -33.77% vs -13.85% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -379.17% vs 75.63% in Dec 2024
About CStone Pharmaceuticals Co. Ltd. 
CStone Pharmaceuticals Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






